Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2014 Jan;29(1):168-78.
doi: 10.1093/ndt/gft212. Epub 2013 Sep 26.

Effects of daily hemodialysis on heart rate variability: results from the Frequent Hemodialysis Network (FHN) Daily Trial

Christopher T Chan  1 , Glenn M Chertow, John T Daugirdas, Tom H Greene, Peter Kotanko, Brett Larive, Andreas Pierratos, John B Stokes; Frequent Hemodialysis Network Daily Trial Group
Affiliations
Randomized Controlled Trial

Effects of daily hemodialysis on heart rate variability: results from the Frequent Hemodialysis Network (FHN) Daily Trial

Christopher T Chan et al. Nephrol Dial Transplant. 2014 Jan.

Abstract

Background: End-stage renal disease is associated with reduced heart rate variability (HRV), components of which generally are associated with advanced age, diabetes mellitus and left ventricular hypertrophy. We hypothesized that daily in-center hemodialysis (HD) would increase HRV.

Methods: The Frequent Hemodialysis Network (FHN) Daily Trial randomized 245 patients to receive 12 months of six versus three times per week in-center HD. Two hundred and seven patients had baseline Holter recordings. HRV measures were calculated from 24-h Holter electrocardiograms at both baseline and 12 months in 131 patients and included low-frequency power (LF, a measure of sympathetic modulation), high-frequency power (HF, a measure of parasympathetic modulation) and standard deviation (SD) of the R-R interval (SDNN, a measure of beat-to-beat variation).

Results: Baseline to Month 12 change in LF was augmented by 50% [95% confidence interval (95% CI) 6.1-112%, P =0.022] and LF + HF was augmented by 40% (95% CI 3.3-88.4%, P = 0.03) in patients assigned to daily hemodialysis (DHD) compared with conventional HD. Changes in HF and SDNN were similar between the randomized groups. The effects of DHD on LF were attenuated by advanced age and diabetes mellitus (predefined subgroups). Changes in HF (r = -0.20, P = 0.02) and SDNN (r = -0.18, P = 0.04) were inversely associated with changes in left ventricular mass (LVM).

Conclusions: DHD increased the LF component of HRV. Reduction of LVM by DHD was associated with increased vagal modulation of heart rate (HF) and with increased beat-to-beat heart rate variation (SDNN), suggesting an important functional correlate to the structural effects of DHD on the heart in uremia.

Keywords: daily hemodialysis; end-stage renal disease; frequent hemodialysis network; heart rate variability; left ventricular mass.

PubMed Disclaimer

Figures

FIGURE 1.
FIGURE 1.
Shown are estimated percent differences in geometric mean changes between the frequent and conventional HD groups, with 95% CIs. The P-values refer to tests of interactions of the treatment with age (as a continuous variable) and diabetic status. The P-values were not adjusted for multiple testing.
FIGURE 2.
FIGURE 2.
Shown are scatter plots relating change from baseline to 12 months in left ventricular mass and in left ventricular EDV to the change in the log transformed high-frequency component within the two treatment groups. Local regression curves are displayed.
FIGURE 3.
FIGURE 3.
Shown are scatter plots relating change from baseline to 12 months in left ventricular mass and in left ventricular EDV to the change in the SD of RR intervals within the two treatment groups. Local regression curves are displayed.
See this image and copyright information in PMC

References

    1. Foley RN. Clinical epidemiology of cardiac disease in dialysis patients: left ventricular hypertrophy, ischemic heart disease, and cardiac failure. Semin Dial. 2003;16:111–117. doi:10.1016/S0002-9343(00)00612-4. - DOI - PubMed
    1. Ranpuria R, Hall M, Chan CT, et al. Heart rate variability (HRV) in kidney failure: measurement and consequences of reduced HRV. Nephrol Dial Transplant. 2008;23:444–449. doi:10.1097/CCM.0b013e318168e375. - DOI - PubMed
    1. La Rovere MT, Bigger JT, Jr, Marcus FI, et al. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (autonomic tone and reflexes after myocardial infarction) Investigators. Lancet. 1998;351:478–484. doi:10.1172/JCI45161. - DOI - PubMed
    1. Chan CT. Heart rate variability in patients with end-stage renal disease: an emerging predictive tool for sudden cardiac death? Nephrol Dial Transplant. 2008;23:3061–3062. doi:10.1016/j.nephro.2006.12.002. - DOI - PubMed
    1. Hausberg M, Kosch M, Harmelink P, et al. Sympathetic nerve activity in end-stage renal disease. Circulation. 2002;106:1974–1979. doi:10.1016/j.ajpath.2010.11.044. - DOI - PubMed

Publication types